HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of hypernephroma with xenogeneic immune RNA.

Abstract
The treatment of patients with hypernephroma with xenogeneic immune RNA was discussed. The toxicity from xenogeneic immune RNA therapy was minimal in patients receiving simple doses from 4 to 64 mg intracutaneously and with cumulative doses of 450 mg during a 30-month period.
AuthorsJ B deKernion, K P Ramming
JournalNational Cancer Institute monograph (Natl Cancer Inst Monogr) Issue 49 Pg. 347-9 (Dec 1978) ISSN: 0083-1921 [Print] United States
PMID748792 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • RNA
Topics
  • Adenocarcinoma (drug therapy, immunology)
  • Humans
  • Immunity
  • Kidney Neoplasms (drug therapy, immunology)
  • RNA (immunology, therapeutic use, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: